DLB · Dolby Laboratories, Inc.
$58.89
-0.17 (-0.29%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$5.53B
Shares
93.67M
Volume · Oct 2
649.75K
Avg daily vol (3M)
951.75K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$58.89
Open$59.45
Day$58.71–59.45
52W close$48.51–72.67
Avg vol 30d1.0M
Short int5.5M · 5.9% float · 6.0d
Short vol59%
Last earningsJul 30, 2026
DataJan 2020–Oct 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 29, 2026
Est · unconfirmed
· in 4 wks
filed Jul 30, 2026
call held Jul 30, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.35B
Trailing 12 months
Net income (TTM)
$226.18M
Trailing 12 months
Revenue growth YoY
-3.3%
Year over year
Operating margin
17.7%
Trailing 12 months
P / E (TTM)
25.2
Trailing earnings · reciprocal yield 4.0%
FCF yield
7.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$670.05M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-2.5%
Year over year · fewer shares
Price change (1Y)
-17.6%
Trailing year
Short interest
5.9%
Latest settlement · 6.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
−1%
below
Price vs 50-day avg
−2%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
43%
mid-range
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−4%
trailing
YTD return
−8%
this year
Relative strength
−17%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $60 › 200d $60 — 50d above 200d
Institutional flow
Accumulating
3 of 392 funds reported for Sep 30 · net +759 sh shares · +1 new
Insider flow
Distributing
Net -$182.5K over 90 days · 100% sells
Short interest
Falling
5.90% of float · ▼ -0.0% MoM · 6.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
392 holders — near 3-yr low, contrarian setup
Squeeze score
72
high risk · 0–100
Fundamentals
Revenue growth
+10%
Y/Y
Gross margin
93%
contracting
EPS growth
−3%
Y/Y
Free cash flow
$435.9M
Valuation
P/E 25.3
in line
Buyback
$427.0M
remaining
Quant / Vol
risk profile
Volatility
30%
annualized · 1-yr
Max drawdown
−33%
past year
ATR
2.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 30, 2026
fourth quarter of fiscal 2026
Total revenue
Initiated
$362M – $392M
prior qtr $305M
midpoint +23.6% QoQ
Licensing revenue
Initiated
$335M – $365M
Gross margins
Initiated
88%
Gross margins
Initiated
90%
Operating expenses
Initiated
$227M – $237M
Effective tax rate
Initiated
23%
Operating expenses
Initiated
$195M – $205M
Diluted earnings per share
Initiated
$0.78 – $0.93
prior qtr $0.30
midpoint +185.0% QoQ
Effective tax rate
Initiated
21%
Diluted earnings per share
Initiated
$1.13 – $1.28
full year of fiscal 2026
Total revenue
Initiated
$1.41B – $1.44B
prior FY $1.35B
midpoint +5.6% Y/Y
Licensing revenue
Initiated
$1.31B – $1.34B
Gross margins
Initiated
88%
Gross margins
Initiated
90%
Operating expenses
Initiated
$937M – $947M
Operating expenses
Initiated
$785M – $795M
Effective tax rate
Initiated
21%
Effective tax rate
Initiated
24%
Diluted earnings per share
Initiated
$2.62 – $2.77
prior FY $2.62
midpoint +2.9% Y/Y
Diluted earnings per share
Initiated
$4.25 – $4.40
Guided vs delivered
· last 8 settled
Diluted earnings per share
full year of fiscal 2024
guided $2.40 – $2.55
$2.69
Beat +8.7%
Total revenue
third quarter of fiscal 2024
guided $270M – $300M
$288.82M
In line
Diluted earnings per share
third quarter of fiscal 2024
guided $0.21 – $0.36
$0.40
Beat +40.4%
Total revenue
full year of fiscal 2024
guided $1.3B
$1.27B
Miss −2.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
−1%
Neutral
Price vs 50-day avg
−2%
Neutral
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
43%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
Golden cross
50d $60 › 200d $60 — 50d above 200d
Institutional flow
Accumulating
3 of 392 funds reported for Sep 30 · net +759 sh shares · +1 new
Insider flow
Distributing
Net -$182.5K over 90 days · 100% sells
Short interest
Falling
5.90% of float · ▼ -0.0% MoM · 6.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
392 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $49
Now $59 · 43%
Range high $73
vs 200-day avg -1%
vs 50-day avg -2%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DLB
this stock
Dolby Laboratories, Inc.
|
$5.53B | -8.3% | +10.3% | 25.3 | 5.9% |
|
CTAS
Cintas Corp
|
$78.56B | +2.6% | +6.4% | 40.0 | 2.8% |
|
RELX
Relx PLC
|
$58.28B | -17.3% | — | — | 0.4% |
|
TRI
Thomson Reuters Corp /Can/
|
$42.89B | -26.0% | — | — | 2.9% |
|
CPRT
Copart Inc
|
$25.27B | -30.5% | +24.7% | 17.6 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DLB | +0.6% | -4.9% | -4.3% | +0.2% | -8.3% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +0.8% | -4.4% | -16.5% | -0.7% | -21.2% |
Capital returns
Buyback programs
· 2 active
· as of Jul 30, 2026
Authorized (total)
$777.00M
Spent (derived)
$350.00M
Remaining
$427.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1308547
CUSIP
25659T107
13F (30d)
10 filings
10 filers
Visit website
Investor relations